The indolent natural history of essential thrombocythemia: A challenge to new drug development

Ayalew Tefferi

doi:10.1016/s0025-6196(11)62964-9

The indolent natural history of essential thrombocythemia: A challenge to new drug development

Ayalew Tefferi

Hematology

Research output: Contribution to journal › Comment/debate › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	97-98
Number of pages	2
Journal	Mayo Clinic proceedings
Volume	80
Issue number	1
DOIs	https://doi.org/10.1016/s0025-6196(11)62964-9
State	Published - Jan 2005

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/s0025-6196(11)62964-9

Cite this

@article{55eb40a294f14af49a8ef13a5a1c61df,

title = "The indolent natural history of essential thrombocythemia: A challenge to new drug development",

author = "Ayalew Tefferi",

year = "2005",

month = jan,

doi = "10.1016/s0025-6196(11)62964-9",

language = "English (US)",

volume = "80",

pages = "97--98",

journal = "Mayo Clinic proceedings",

issn = "0025-6196",

publisher = "Elsevier Science",

number = "1",

}

TY - JOUR

T1 - The indolent natural history of essential thrombocythemia

T2 - A challenge to new drug development

AU - Tefferi, Ayalew

PY - 2005/1

Y1 - 2005/1

UR - http://www.scopus.com/inward/record.url?scp=11344257365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11344257365&partnerID=8YFLogxK

U2 - 10.1016/s0025-6196(11)62964-9

DO - 10.1016/s0025-6196(11)62964-9

M3 - Comment/debate

C2 - 15667035

AN - SCOPUS:11344257365

SN - 0025-6196

VL - 80

SP - 97

EP - 98

JO - Mayo Clinic proceedings

JF - Mayo Clinic proceedings

IS - 1

ER -

The indolent natural history of essential thrombocythemia: A challenge to new drug development

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this